2021

Rapetto, F., Taliotis, D., Chen, Q., Ttofi, I., Iacobazzi, D., Madeddu, P., ...Caputo, M. (2021). Allogeneic Mesenchymal Stromal Cell Injection to Alleviate Ischemic Heart Failure Following Arterial Switch Operation.. JACC: Case Reports, 3 (5), 724-727. doi:10.1016/j.jaccas.2021.02.039
Graham, R., Kolluri, K., Davies, A., Weil, B., Day, A., Popova, B., ...Forster, M. (2021). ASSESSING THE IMMUNOGENICITY OF ANTI-CANCER CELL THERAPY MSCTRAIL.
Roddie, C., Dias, J., O'Reilly, M.A., Abbasian, M., Cadinanos-Garai, A., Vispute, K., ...Roddy, H. (2021). Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia. Journal of Clinical Oncology, doi:10.1200/jco.21.00917
Tait, A., Proctor, T., Hamilton, N.J.I., Birchall, M.A., Lowdell, M.W. (2021). GMP compliant isolation of mucosal epithelial cells and fibroblasts from biopsy samples for clinical tissue engineering. Scientific Reports, 11 (1), doi:10.1038/s41598-021-91939-0
Luck, J., Weil, B., Mosahebi, A., Lowdell, M. (2021). MANUFACTURE AND CHARACTERISATION OF EX VIVO EXPANDED ADIPOSE-DERIVED STEM CELLS FOR CUTANEOUS WOUND HEALING APPLICATIONS.
Samuel, E.R., Rologi, E., Fraser, H., Sassi, M., Pruchniak, M., Kotsiou, E., ...Carolan, C. (2021). Validation of the Achilles VELOS process 2 manufacturing platform for the treatment of solid cancer: GMP scale runs generate a significant dose boost of highly potent clonal neoantigen reactive T-cells.

2020

Mehra, V., Mitsikakou, M., Pinto, J.D.A., Shafat, M.S., Peggs, K.S., Lowdell, M., ...Roddie, C. (2020). Akt Inhibition Enhances Memory, Proliferation and Cytotoxicity in CD19 CAR T Cells.
Roddie, C., O'Reilly, M.A., Marzolini, M.A.V., Wood, L., Dias, J., Garai, A.C., ...Wheeler, G. (2020). ALLCAR19: Updated Data Using AUTO1, a Novel Fast-Off Rate CD19 CAR in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukaemia and Other B-Cell Malignancies.
Weil, B., Bain, O., Rego, R.T., Lowdell, M. (2020). Bioprocess solutions to assess clinical biodistribution in cell/gene therapies.
Awan, M., Buriak, I., Fleck, R., Fuller, B., Goltsev, A., Kerby, J., ...Petrenko, Y. (2020). Dimethyl sulfoxide: a central player since the dawn of cryobiology, is efficacy balanced by toxicity?. Regenerative Medicine, doi:10.2217/rme-2019-0145
Robertson, N.J., Meehan, C., Martinello, K.A., Avdic-Belltheus, A., Boggini, T., Mutshiya, T., ...Charalambous, X. (2020). Human umbilical cord mesenchymal stromal cells as an adjunct therapy with therapeutic hypothermia in a piglet model of perinatal asphyxia.. Cytotherapy, doi:10.1016/j.jcyt.2020.10.005
Jones, D.A., Baca, G.L., Hussain, M., Jardim, V., Davies, L.C., Veerapen, J.V., ...Mathur, A. (2020). Intracoronary autologous bone marrow mononuclear cells for the compassionate treatment of advanced heart failure.
Al Belushi, H.K., Birchall, M.A., Lowdell, M. (2020). Investigation of bioactive molecules released by MSCs seeded on decellularized tracheal scaffolds for airway tissue engineering.
Sabry, M., Lowdell, M.W. (2020). Killers at the crossroads: The use of innate immune cells in adoptive cellular therapy of cancer.. Stem Cells Transl Med, doi:10.1002/sctm.19-0423
Patrick, P.S., Kolluri, K.K., Zaw Thin, M., Edwards, A., Sage, E.K., Sanderson, T., ...Lowdell, M. (2020). Lung delivery of MSCs expressing anti-cancer protein TRAIL visualised with ⁸⁹Zr-oxine PET-CT. Stem Cell Research and Therapy, 11 (1), 256. doi:10.1186/s13287-020-01770-z
Davies, A., Sage, B., Kolluri, K., Graham, R., Alrifai, D., Weil, B., ...Popova, B. (2020). Novel biomarker-driven trial of a cell and gene therapy for the treatment of malignant pleural mesothelioma (MPM): the STRATEGIC trial.
Cuadrado, M.M., Szydlo, R.M., Watts, M., Patel, N., Renshaw, H., Dorman, J., ...Madrigal, A. (2020). Predictors of recovery following allogeneic CD34+-selected cell infusion without conditioning to correct poor graft function.. Haematologica, 105 (11), 2639-2646. doi:10.3324/haematol.2019.226340
Fraser, H., Pike, R., Thirkell, S., Arshad, A., Jide-Banwo, S., Bartley, H., ...Mootien, J. (2020). The development of a personalized autologous clonal neoantigen T cell therapy for the treatment of solid cancer using the VELOS (TM) manufacturing platform generates highly potent and reactive CD8+and CD4+T cells for clinical use.

2019

Luck, J., Weil, B.D., Lowdell, M., Mosahebi, A. (2019). Adipose-Derived Stem Cells for Regenerative Wound Healing Applications: Understanding the Clinical and Regulatory Environment.. Aesthet Surg J, doi:10.1093/asj/sjz214
Hanley, P.J., Lowdell, M.A.R.K. (2019). Advancing cellular therapies towards standard of care: a focus on testing of cellular therapy products. Cytotherapy, 21 (3), 275-277. doi:10.1016/j.jcyt.2019.02.003
Roddie, C., O'Reilly, M.A., Marzolini, M.A.V., Wood, L., Pinto, J.D.A., Abbasian, M., ...Olejnik, J. (2019). AUTO1, a Novel Fast Off CD19CAR Delivers Durable Remissions and Prolonged CAR T Cell Persistence with Low CRS or Neurotoxicity in Adult ALL.
Roddie, C., O'Reilly, M.A., Marzolini, M.A.V., Wood, L., Pinto, J.D.A., Abbasian, M., ...Wheeler, G. (2019). Automated Manufacture of Matched Donor-Derived Allogeneic CD19 CAR T-Cells for Relapsed/Refractory B-ALL Following Allogeneic Stem Cell Transplantation: Toxicity, Efficacy and the Important Role of Lymphodepletion.
Wagner, A.K., ALICI, E., LOWDELL, M.W. (2019). Characterization of human natural killer cells for therapeutic use. Cytotherapy, doi:10.1016/j.jcyt.2018.11.001
Joseph, A., Lin, S.H.S., Haso, W., Gumlaw, N., Lowdell, M., Kassim, S.H., Patel, E. (2019). CTV-1-Activated CAR-NK (MBIO-109): A Potent "Off-The-Shelf" Tumoricidal Therapeutic.
Roddie, C., O'Reilly, M., Dias Alves Pinto, J., Vispute, K., Lowdell, M. (2019). Manufacturing chimeric antigen receptor T cells: issues and challenges. Cytotherapy, doi:10.1016/j.jcyt.2018.11.009
Tsirogianni, M., Grigoriou, E., Kapsimalli, V., Dagla, K., Stamouli, M., Gkirkas, K., ...Stavroulaki, G. (2019). Natural killer cell cytotoxicity is a predictor of outcome for patients with high risk myelodysplastic syndrome and oligoblastic acute myeloid leukemia treated with azacytidine. Leukemia and Lymphoma, 1-7. doi:10.1080/10428194.2019.1581935
Shafat, M.S., Dias, J., Palton, M., Lowdell, M., Pule, M., Peggs, K.S., Roddie, C. (2019). Next Generation T-Cell Therapy for CMV Infection Post Allogeneic SCT.
Weil, B., Hanley, P.J., Lowdell, M. (2019). Proposal for the International Society for Cell & Gene Therapy position statement on assays for the quality control and potency assessment of adoptive cellular immunotherapies.. Cytotherapy, doi:10.1016/j.jcyt.2019.02.001
Davies, A., Sage, E., Kolluri, K., Graham, R., Weil, B., Rego, R., ...Day, A. (2019). TACTICAL: A Phase I/II Trial to Assess the Safety and Efficacy of MSCTRAIL in Metastatic Lung Adenocarcinoma.
Sage, E.K., Davies, A., Kolluri, K., Alrifai, D., Graham, R., Weil, B., ...Santilli, G. (2019). TACTICAL: A phase I/II trial to assess the safety and efficacy of MSCTRAIL in metastatic lung adenocarcinoma.
Davies, A., Sage, B., Kolluri, K., Alrifai, D., Graham, R., Weil, B., ...Champion, K. (2019). TACTICAL: A phase I/II trial to assess the safety and efficacy of MSCTRAIL in the treatment of metastatic lung adenocarcinoma.
TENDEIRO REGO, R.I.T.A., MORRIS, E.C., LOWDELL, M.W. (2019). T-cell receptor gene-modified cells: past promises, present methodologies and future challenges. Cytotherapy, doi:10.1016/j.jcyt.2018.12.002
Sabry, M., Zubiak, A., Hood, S.P., Simmonds, P., Arellano-Ballestero, H., Cournoyer, E., ...Lowdell, M.W. (2019). Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures. PLoS One, 14 (6), e0218674. doi:10.1371/journal.pone.0218674
Colicchia, M., Jones, D.A., Beirne, A.-.M., Hussain, M., Weeraman, D., Rathod, K., ...Mathur, A. (2019). Umbilical cord-derived mesenchymal stromal cells in cardiovascular disease: review of preclinical and clinical data. CYTOTHERAPY, 21 (10), 1007-1018. doi:10.1016/j.jcyt.2019.04.056
Hamilton, N., Hynds, R., Gowers, K., Tait, A., Butler, C., Hopper, C., ...Janes, S.M. (2019). Using a 3D collagen matrix to deliver respiratory progenitor cells to decellularized trachea in vivo. Tissue Engineering Part C: Methods, doi:10.1089/ten.TEC.2018.0241

2018

Fehniger, T.A., Miller, J.S., Stuart, R.K., Cooley, S., Salhotra, A., Curtsinger, J., ...Silver, N. (2018). A Phase 1 Trial of CNDO-109–Activated Natural Killer Cells in Patients with High-Risk Acute Myeloid Leukemia. Biology of Blood and Marrow Transplantation, doi:10.1016/j.bbmt.2018.03.019
Antoniadou, E., Ramachandra, D., Subramaniam, S., Lowdell, M., DeCoppi, P., David, A. (2018). Manufacturing clinical-grade human amniotic fluid stem cells for translational regenerative medicine applications.
Urbani, L., Camilli, C., Phylactopoulos, D.E., Crowley, C., Natarajan, D., Scottoni, F., ...Urciuolo, A. (2018). Multi-stage bioengineering of a layered oesophagus with in vitro expanded muscle and epithelial adult progenitors. Nature Communications, doi:10.1038/s41467-018-06385-w
Cuadrado, M.D.M., Lowdell, M.W., Ings, S., Watts, M.J., Szydlo, R., Anthias, C., ...Hough, R. (2018). Predictors of Response in Patients Receiving CD34-Selected Stem Cell Infusions without Conditioning to Correct Graft Failure Following Allogeneic Stem Cell Transplantation.
Mehrban, N., Bowen, J., Tait, A., Darbyshire, A., Virasami, A.K., Lowdell, M.W., Birchall, M.A. (2018). Silsesquioxane polymer as a potential scaffold for laryngeal reconstruction. Materials Science and Engineering C, 92 565-574. doi:10.1016/j.msec.2018.07.003
Al Belushi, H.K., Birchall, M.A., Lowdell, M. (2018). TAKING A CLEAR LOOK: USE OF OPTICAL CLEARING FOR EVALUATION OF SEEDING DISTRIBUTION AND BIOMASS OF MSCS SEEDED THREE DIMENSIONAL DECELLULARISED SCAFFOLDS.
Sage, E., Davies, A., Kolluri, K., Patrick, S., Weil, B., Rego, R.V.T.P., ...Thakrar, R. (2018). Targeted stem cells expressing TRAIL as a therapy for lung Cancer TACTICAL: a phase I/II trial.

2017

Hachani, R., Birchall, M.A., Lowdell, M.W., Kasparis, G., Tung, L.D., Manshian, B.B., ...Gharagouzloo, C.A. (2017). Assessing cell-nanoparticle interactions by high content imaging of biocompatible iron oxide nanoparticles as potential contrast agents for magnetic resonance imaging.. Scientific reports, 7 (1), 7850. doi:10.1038/s41598-017-08092-w
Maughan, E.F., Hynds, R.E., Proctor, T.J., Janes, S.M., Elliott, M., Birchall, M.A., ...De Coppi, P. (2017). Autologous Cell Seeding in Tracheal Tissue Engineering.. Current stem cell reports, 3 (4), 279-289. doi:10.1007/s40778-017-0108-2
Tait, A., Charalambous, X., Proctor, T., Tsagovits, K., Hamilton, N., Veraitch, F., ...Lowdell, M. (2017). CREATING GMP EPITHELIAL AND FIBROBLAST CELLS FROM A SINGLE BIOPSY FOR THE POTENTIAL USE IN TISSUE ENGINEERING.
Lee, E., Milan, A., Urbani, L., De Coppi, P., Lowdell, M.W. (2017). Decellularized material as scaffolds for tissue engineering studies in long gap esophageal atresia. EXPERT OPINION ON BIOLOGICAL THERAPY, 17 (5), 573-584. doi:10.1080/14712598.2017.1308482
Al Belushi, H.K., Zani, L., Liu, Y., Silberschmidt, V., Lowdell, M., Li, S. (2017). EVALUATION OF THE CHEMICAL AND BIOMECHANICAL VISCOELASTIC PROPER IRS OF DECELLULARISED TRACHEAL SCAFFOLDS.
Herrmann, P., Ansari, T., Southgate, A., Varanou Jenkins, A., Partington, L., Carvalho, C., ...Birchall, M.A. (2017). In vivo implantation of a tissue engineered stem cell seeded hemi-laryngeal replacement maintains airway, phonation and swallowing in pigs.. Journal of tissue engineering and regenerative medicine, doi:10.1002/term.2596
Mavroudis, C.A., Eleftheriou, D., Hong, Y., Majumder, B., Koganti, S., Sapsford, R., ...Brogan, P. (2017). Microparticles in acute coronary syndrome. Thrombosis Research, 156 109-116. doi:10.1016/j.thromres.2017.06.003
Domogala, A., Blundell, M., Thrasher, A., Lowdell, M.W., Madrigal, J.A., Saudemont, A. (2017). Natural killer cells differentiated in vitro from cord blood CD34+ cells are more advantageous for use as an immunotherapy than peripheral blood and cord blood natural killer cells. Cytotherapy, doi:10.1016/j.jcyt.2017.03.068
Al Belushi, H.K., Tait, A., Charalambous, X., Birchall, M.A., Lowdell, M. (2017). OPTIMISATION OF PASSIVE CELLS SEEDING EFFICIENCY FOR MESENCHYMAL STROMAL CELLS SEEDED DECELLULARISED TRACHEAL SCAFFOLD FOR AIRWAY TISSUE ENGINEERING.
Lange, P., Greco, K., Partington, L., Carvalho, C., Oliani, S., Birchall, M.A., ...Ansari, T. (2017). Pilot study of a novel vacuum-assisted method for decellularization of tracheae for clinical tissue engineering applications. JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 11 (3), 800-811. doi:10.1002/term.1979
Proctor, T., Carvalho, C., Tait, A., Charalambous, X., Jide-Banwo, S., Bartley, H., ...Lowdell, M. (2017). PRODUCTION OF TISSUE ENGINEERED LARYNX AND EPITHELIUM IN A SINGLE GMP-COMPLIANT BIOREACTOR.
Ansari, T., Lange, P., Southgate, A., Greco, K., Carvalho, C., Partington, L., ...Sibbons, P.D. (2017). Stem Cell-Based Tissue-Engineered Laryngeal Replacement.. Stem Cells Transl Med, doi:10.5966/sctm.2016-0130
Davies, A.V., Sage, E.K., Kolluri, K., Weil, B., Rego, R.V.T.P., Edwards, A., ...Champion, K. (2017). TARGETED STEM CELLS EXPRESSING TRAIL AS A THERAPY FOR LUNG CANCER TACTICAL: A PHASE I/II TRIAL.
Ireland, H., Gay, M.H.P., Baldomero, H., De Angelis, B., Baharvand, H., Lowdell, M.W., ...Martin, I. (2017). The survey on cellular and tissue-engineered therapies in Europe and neighboring Eurasian countries in 2014 and 2015. Cytotherapy, doi:10.1016/j.jcyt.2017.08.009
Elliott, M.J., Butler, C.R., Varanou-Jenkins, A., Partington, L., Carvalho, C., Samuel, E., ...Hynds, R.E. (2017). Tracheal Replacement Therapy with a Stem Cell-Seeded Graft: Lessons from Compassionate Use Application of a GMP-Compliant Tissue-Engineered Medicine. STEM CELLS TRANSLATIONAL MEDICINE, 6 (6), 1458-1464. doi:10.1002/sctm.16-0443
Butler, C.R., Hynds, R.E., Crowley, C., Gowers, K.H.C., Partington, L., Hamilton, N.J., ...Burns, A.J. (2017). Vacuum-assisted decellularization: an accelerated protocol to generate tissue-engineered human tracheal scaffolds. Biomaterials, doi:10.1016/j.biomaterials.2017.02.001
Forte, M., Lowdell, M., Rezvani, K. (2017). Welcome to ISCT 2017 London. CYTOTHERAPY, 19 (5), S1-S2. doi:10.1016/j.jcyt.2017.03.007

2016

Camilli, C., Urbani, L., Scottoni, F., Crowley, C., Wong, R.R., Maghsoudlou, P., ...Cossu, G. (2016). Artificial Oesophagus Engineering in a 3D Dynamic Culture (vol 61, pg 509, 2015).
Culme-Seymour, E.J., Mason, K., Vallejo-Torres, L., Carvalho, C., Partington, L., Crowley, C., ...Elliott, M.J. (2016). Cost of Stem Cell-Based Tissue-Engineered Airway Transplants in the United Kingdom: Case Series. TISSUE ENGINEERING PART A, 22 (3-4), 208-213. doi:10.1089/ten.tea.2015.0283
Yuan, Z., Lourenco, S.D.S., Sage, E.K., Kolluri, K.K., Lowdell, M.W., Janes, S.M. (2016). Cryopreservation of human mesenchymal stromal cells expressing TRAIL for human anti-cancer therapy. CYTOTHERAPY, 18 (7), 860-869. doi:10.1016/j.jcyt.2016.04.005
de Wilde, S., Guchelaar, H.-.J., Herberts, C., Lowdell, M., Hildebrandt, M., Zandvliet, M., Meij, P. (2016). Development of cell therapy medicinal products by academic institutes. DRUG DISCOVERY TODAY, 21 (8), 1206-1212. doi:10.1016/j.drudis.2016.04.016
Verfuerth, S., Sousa, P.S.E., Beloki, L., Murray, M., Peters, M.D., O'Neill, A.T., ...Samuel, E.R. (2016). Generation of memory T cells for adoptive transfer using clinical-grade anti-CD62L magnetic beads (vol 50, pg 1358, 2015). Bone Marrow Transplantation, 51 (4), 620. doi:10.1038/bmt.2016.30
Majumder, B., Koganti, S., Lowdell, M.W., Rakhit, R.D. (2016). Intracoronary platelet and monocyte activation status within platelet-monocyte complexes are determinants of inflammation in ST elevation myocardial infarction1. Clinical Hemorheology and Microcirculation, 64 (1), 35-46. doi:10.3233/CH-162040
Horlock, C., Skulte, A., Mitra, A., Stansfield, A., Bhandari, S., Ip, W., ...Friedetzky, A. (2016). Manufacture of GMP-compliant functional adenovirus-specific T-cell therapy for treatment of post-transplant infectious complications.. Cytotherapy, doi:10.1016/j.jcyt.2016.06.009
Hachani, R., Lowdell, M., Birchall, M., Hervault, A., Mertz, D., Begin-Colin, S., Thanh, N.T. (2016). Polyol synthesis, functionalisation, and biocompatibility studies of superparamagnetic iron oxide nanoparticles as potential MRI contrast agents. Nanoscale, 8 (6), 3278-3287. doi:10.1039/c5nr03867g
Hachani, R., Lowdell, M., Birchall, M., Hervault, A., Mertz, D., Begin-Colin, S., Nguyen, T.K.T. (2016). Polyol synthesis, functionalisation, and biocompatibility studies of superparamagnetic iron oxide nanoparticles as potential MRI contrast agents (vol 8, pg 3278, 2016). NANOSCALE, 8 (7), 4395. doi:10.1039/c5nr90206a
Culme-Seymour, E.J., Carvalho, C., Bain, O., Omakobia, E., Wilson, S., Knowles, H., ...Ambler, G. (2016). RegenVOX - Translational Exploitation Strategy for Stem Cell-Based Tissue-Engineered Laryngeal Implants Undergoing Phase I/II Clinical Trial.
Hamilton, N.J., Kanani, M., Roebuck, D.J., Hewitt, R.J., Cetto, R., McLaren, C.A., ...O'Callaghan, C. (2016). Reply to: "recent Advances in Circumferential Tracheal Replacement and Transplantation". American Journal of Transplantation, 16 (4), 1336-1337. doi:10.1111/ajt.13736
Lowdell, M.W., Thomas, A. (2016). The expanding role of the clinical haematologist in the new world of advanced therapy medicinal products. British Journal of Haematology, doi:10.1111/bjh.14384
Domogala, A., Blundell, M., Laza-Briviesca, R., Thrasher, A., Lowdell, M., Madrigal, A., Saudemont, A. (2016). Unstimulated Natural Killer Cells Differentiated in Vitro from Umbilical Cord Blood CD34+ Cells Kill Patient AML Blasts in Vivo.

2015

Koehl, U., Kalberer, C., Spanholtz, J., Lee, D.A., Miller, J.S., Cooley, S., ...Curti, A. (2015). Advances in clinical NK cell studies: Donor selection, manufacturing and quality control. OncoImmunology, 5 (4), doi:10.1080/2162402X.2015.1115178
Beloki, L., Ciaurriz, M., Mansilla, C., Zabalza, A., Perez-Valderrama, E., Samuel, E.R., ...Olavarria, E. (2015). Assessment of the effector function of CMV-specific CTLs isolated using MHC-multimers from granulocyte-colony stimulating factor mobilized peripheral blood. JOURNAL OF TRANSLATIONAL MEDICINE, 13 doi:10.1186/s12967-015-0515-z
Culme-Seymour, E., Mason, K., Vallejo-Torres, L., Carvalho, C., Partington, L., Crowley, C., ...Elliott, M.J. (2015). COST OF STEM CELL-BASED TISSUE-ENGINEERED AIRWAY TRANSPLANTS IN THE UK: CASE SERIES. CYTOTHERAPY, 17 (6), S14-S15. doi:10.1016/j.jcyt.2015.03.332
Urbani, L., Camilli, C., Crowley, C., Scottoni, F., Fallas, M.E.A., Urciuolo, A., ...Lowdell, M. (2015). Development of an Artificial Oesophagus Engineered with Mesoangioblasts in a Peristaltic 3d Dynamic Culture.
Verfuerth, S., Sousa, P.S.E., Beloki, L., Murray, M., Peters, M.D., Mackinnon, S., ...Samuel, E.R. (2015). Generation of memory T cells for adoptive transfer using clinical-grade anti-CD62L magnetic beads. BONE MARROW TRANSPLANTATION, 50 (10), 1358-1364. doi:10.1038/bmt.2015.135
Camilli, C., Urbani, L., Scottoni, F., Crowley, C., Wong, R.R., Maghsoudlou, P., ...Cossu, G. (2015). OP-1 ARTIFICIAL OESOPHAGUS ENGINEERING IN A 3D DYNAMIC CULTURE..
Birchall, M.A., Schilder, A.G., Janes, S., Ansari, T., Tebbs, S., Sheridan, R., ...Carvalho, C. (2015). REGENVOX: A PHASE I/II CLINICAL TRIAL OF STEM CELL-BASED TISSUE-ENGINEERED LARYNGEAL IMPLANTS. CYTOTHERAPY, 17 (6), S69. doi:10.1016/j.jcyt.2015.03.541
Chabannon, C., Hildebrandt, M., Scheding, S., Humpe, A., Lowdell, M., Slaper-Cortenbach, I. (2015). Regulation of advanced therapy medicinal products will affect the practice of haematopoietic SCT in the near future: A perspective from the EBMT cell-processing committee. Bone Marrow Transplantation, 50 (3), 321-323. doi:10.1038/bmt.2014.271
Chabannon, C., Hildebrandt, M., Scheding, S., Humpe, A., Lowdell, M., Slaper-Cortenbach, I. (2015). Regulation of advanced therapy medicinal products will affect the practice of haematopoietic SCT in the near future: a perspective from the EBMT cell-processing committee.. BONE MARROW TRANSPLANTATION, 50 (3), 321-323. doi:10.1038/bmt.2014.271
Hamilton, N.J., Kanani, M., Roebuck, D.J., Hewitt, R.J., Cetto, R., Culme-Seymour, E.J., ...McLaren, C.A. (2015). Tissue-engineered tracheal replacement in a child: a 4-year follow-up study. Am J Transplant, 15 (10), 2750-2757. doi:10.1111/ajt.13318
Kottaridis, P.D., North, J., Tsirogianni, M., Marden, C., Samuel, E.R., Jide-Banwo, S., ...Lowdell, M.W. (2015). Two-Stage Priming of Allogeneic Natural Killer Cells for the Treatment of Patients with Acute Myeloid Leukemia: A Phase I Trial. PLoS One, 10 (6), doi:10.1371/journal.pone.0123416
Bartley, H., Clarke, L., Lowdell, M., Samuel, E.R. (2015). VALIDATION OF THE CliniMACS PRODIGY FOR MANUFACTURE OF TUMOR-PRIMED NATURAL KILLER CELLS (TpNK). CYTOTHERAPY, 17 (6), S83. doi:10.1016/j.jcyt.2015.03.597

2014

Wasmann, R., Hildebrandt, M., Lowdell, M., Slaper-Cortenbach, I., Grp, A.G.O.R.A.P. (2014). AGORA survey: ATMP regulatory differences identified in Europe.
Fishman, J.M., Wiles, K., Lowdell, M.W., De Coppi, P., Elliott, M.J., Atala, A., Birchall, M.A. (2014). Airway tissue engineering: an update.. EXPERT OPINION ON BIOLOGICAL THERAPY, 14 (10), 1477-1491. doi:10.1517/14712598.2014.938631
Samuel, E.R., Beloki, L., Hood, J., Murray, M., Chakraverty, R., Lowdell, M. (2014). CLINICAL-GRADE DEPLETION OF NAIVE T CELLS USING IMMUNOMAGNETIC CD62L BEADS: APPLICATION FOR ADOPTIVE IMMUNOTHERAPY AND ALLODEPLETION WITH MAINTENANCE OF CENTRAL AND EFFECTOR MEMORY T CELLS. CYTOTHERAPY, 16 (4), S108-S109. doi:10.1016/j.jcyt.2014.01.400
Beloki, L., Ciaurriz, M., Mansilla, C., Zabalza, A., Perez-Valderrama, E., Samuel, E.R., ...Olavarria, E. (2014). CMV-specific T cell isolation from G-CSF mobilized peripheral blood: depletion of myeloid progenitors eliminates non-specific binding of MHC-multimers.. JOURNAL OF TRANSLATIONAL MEDICINE, 12 doi:10.1186/s12967-014-0317-8
Träger, U., Andre, R., Lahiri, N., Magnusson-Lind, A., Weiss, A., Grueninger, S., ...Pfister, E.L. (2014). HTT-lowering reverses Huntington's disease immune dysfunction caused by NFκB pathway dysregulation.. Brain, 137 819-833. doi:10.1093/brain/awt355
Samuel, E.R., Beloki, L., Newton, K., Mackinnon, S., Lowdell, M.W. (2014). Isolation of highly suppressive CD25+FoxP3+ T regulatory cells from G-CSF-mobilized donors with retention of cytotoxic anti-viral CTLs: application for multi-functional immunotherapy post stem cell transplantation.. PLoS One, 9 (1), doi:10.1371/journal.pone.0085911
Beloki, L., Samuel, E.R., Ramirez, N., Olavarria, E., Lowdell, M. (2014). MANUFACTURING OF CMV-SPECIFIC T CELLS FROM G-CSF MOBILISED DONORS FOR ADOPTIVE IMMUNOTHERAPY THAT PRESERVE STRONG ANTI-VIRAL AND CYTOTOXIC ACTIVITY. CYTOTHERAPY, 16 (4), S20. doi:10.1016/j.jcyt.2014.01.062
Beloki, L., Ramírez, N., Olavarría, E., Samuel, E.R., Lowdell, M.W. (2014). Manufacturing of highly functional and specific T cells for adoptive immunotherapy against virus from granulocyte colony-stimulating factor-mobilized donors. Cytotherapy, 16 (10), 1390-1408. doi:10.1016/j.jcyt.2014.05.009
Beloki, L., Ramírez, N., Olavarría, E., Samuel, E.R., Lowdell, M.W. (2014). Manufacturing of highly functional and specific T cells for adoptive immunotherapy against virus from granulocyte colony-stimulating factor-mobilized donors.. CYTOTHERAPY, 16 (10), 1390-1408. doi:10.1016/j.jcyt.2014.05.009
Fishman, J.M., Wormald, J.C.R., Lowdell, M.W., Coppi, P.D.E., Birchall, M.A. (2014). Operating RegenMed: development of better in-theater strategies for handling tissue-engineered organs and tissues.. Regen Med, 9 (6), 785-791. doi:10.2217/rme.14.46
Fehniger, T.A., Stuart, R.K., Cooley, S.A., Miller, J.S., Curtsinger, J., Hillman, T.M., ...Gorelik, L. (2014). Preliminary Results of a Phase 1/2 Clinical Trial of Cndo-109-Activated Allogeneic Natural Killer Cells in High Risk Acute Myelogenous Leukemia Patients in First Complete Remission.
Pearce, K.F., Hildebrandt, M., Greinix, H., Scheding, S., Koehl, U., Worel, N., ...Mischak-Weissinger, E. (2014). Regulation of advanced therapy medicinal products in Europe and the role of academia. CYTOTHERAPY, 16 (3), 289-297. doi:10.1016/j.jcyt.2013.08.003
Sabry, M., Cournoyer, E., Mashar, M., Lowdell, M.W. (2014). Regulation of NK cell responses by target cell recognition. IMMUNOLOGY, 143 100.
Fishman, J.M., Lowdell, M., Birchall, M.A. (2014). Stem cell-based organ replacements—Airway and lung tissue engineering. SEMINARS IN PEDIATRIC SURGERY, 23 (3), 119-126. doi:10.1053/j.sempedsurg.2014.04.002
Wallace, R., Flutter, B., Morgenestern, D., Hargrave, D., Blanco, E., Howe, K., ...Anderson, J. (2014). TUMOUR LYSATE PULSED DENDRITIC CELL VACCINATION FOR CHILDREN WITH HIGH GRADE GLIOMA.

2013

Birchall, M.A., Elliott, M.J., Lowdell, M., De Coppi, P. (2013). Authors' reply. Lancet, 381 113-. doi:10.1016/S0140-6736(13)60044-6
Fishman, J.M., Lowdell, M., Ansari, T., Sibbons, P., De Coppi, P., Birchall, M.A. (2013). Characterisation and immunogenicity of a decellularised skeletal muscle scaffold for laryngeal tissue engineering.
Knight, A., Arnouk, H., Britt, W., Gillespie, G.Y., Cloud, G.A., Harkins, L., ...Lamb, L.S. (2013). CMV-independent lysis of glioblastoma by ex vivo expanded/activated Vδ1+ γδ T cells.. PLoS One, 8 (8), doi:10.1371/journal.pone.0068729
Fishman, J.M., Lowdell, M.W., Urbani, L., Ansari, T., Burns, A.J., Turmaine, M., ...Wood, K.J. (2013). Immunomodulatory effect of a decellularized skeletal muscle scaffold in a discordant xenotransplantation model. Proc Natl Acad Sci USA, 110 (35), 14360-14365. doi:10.1073/pnas.1213228110
Träger, U., Magnusson, A., Lahiri Swales, N., Wild, E., North, J., Lowdell, M., Björkqvist, M. (2013). JAK/STAT Signalling in Huntington's Disease Immune Cells.. PLoS Currents, (DEC), doi:10.1371/currents.hd.5791c897b5c3bebeed93b1d1da0c0648
Beloki, L., Samuel, E., Ramirez, N., Olavarria, E., Lowdell, M.W. (2013). Manufacturing of highly specific and functional T cells for adoptive immunotherapy from G-CSF-mobilised donors based on activation-dependent CD137 expression.
Lowdell, M.W., Morris, E. (2013). Recent Advances in Clinical Cellular Immunotherapy. 473-479. doi:10.1002/9781118520093.ch43
Samuel, E.R., Newton, K., MacKinnon, S., Lowdell, M.W. (2013). Successful isolation and expansion of CMV-reactive T cells from G-CSF mobilized donors that retain a strong cytotoxic effector function. British Journal of Haematology, 160 (1), 87-100. doi:10.1111/bjh.12082
Samuel, E.R., Newton, K., Mackinnon, S., Lowdell, M.W. (2013). Successful isolation and expansion of CMV-reactive T cells from G-CSF mobilized donors that retain a strong cytotoxic effector function. BRITISH JOURNAL OF HAEMATOLOGY, 160 (1), 87-100. doi:10.1111/bjh.12082
Hildebrandt, M., Apperley, J., Dickinson, A.M., Edinger, M., Greinix, H., Hauser, A., ...Scheding, S. (2013). The Regulation of Advanced Therapy Medicinal Products (ATMPs) in Europe and the Role of Academia: Results of an FP7-funded Research Project. ONKOLOGIE, 36 264.
Lowdell, M.W., Pearce, K.F., Apperley, J., Dickinson, A.M., Edinger, M., Greinix, H., ...Scheding, S. (2013). The regulation of advanced therapy medicinal products in Europe and the role of academia.
Pearce, K.F., Hildebrandt, M.O., Scheding, S., Koehl, U., Mischak-Weissinger, E., Hauser, A., ...Apperley, J. (2013). THE REGULATION OF ADVANCED THERAPY MEDICINAL PRODUCTS IN EUROPE AND THE ROLE OF ACADEMIA. CYTOTHERAPY, 15 (4), S51-S52. doi:10.1016/j.jcyt.2013.01.200
Sabry, M., Lowdell, M.W. (2013). The unique profile of tumour-primed natural killer cells shows loss of activating receptor expression and pro-inflammatory cytokine secretion upon activation.
Warner, E., Birchall, M., Lowdell, M.W. (2013). Tissue banking in ENT: challenges and methods.. JOURNAL OF LARYNGOLOGY AND OTOLOGY, 127 (7), 630-637. doi:10.1017/S0022215113001321
Hachani, R., Lowdell, M., Birchall, M., Thanh, N.T.K. (2013). Tracking stem cells in tissue-engineered organs using magnetic nanoparticles. Nanoscale, 5 (23), 11362-11373.
Sabry, M., Lowdell, M.W. (2013). Tumor-primed NK cells: waiting for the green light.. Front Immunol, 4 doi:10.3389/fimmu.2013.00408

2012

Oseni, A., Crowley, C., Lowdell, M., Birchall, M., Butler, P.E., Seifalian, A.M. (2012). Advancing nasal reconstructive surgery: The application of tissue engineering technology. Journal of Tissue Engineering and Regenerative Medicine, 6 (10), 757-768. doi:10.1002/term.487
Oseni, A., Crowley, C., Lowdell, M., Birchall, M., Butler, P.E., Seifalian, A.M. (2012). Advancing nasal reconstructive surgery: the application of tissue engineering technology.. JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 6 (10), 757-768. doi:10.1002/term.487
Partington, L., Mordan, N.J., Mason, C., Knowles, J.C., Kim, H.W., Lowdell, M.W., ...Wall, I.B. (2012). Biochemical changes caused by decellularization may compromise mechanical integrity of tracheal scaffolds. Eur Cell Mater, 23
Fishman, J., Ansari, T., Sibbons, P., Lowdell, M., De Coppi, P., Birchall, M. (2012). Characterisation and immunogenicity of a decellularised skeletal muscle scaffold for laryngeal tissue engineering.
Knight, A., Arnouk, H., Gillespie, G., Britt, W., Su, Y., Lowdell, M.W., Lamb, L.S. (2012). CYTOMEGALOVIRUS-INDEPENDENT LYSIS OF GLIOMA-DERIVED CELL LINES AND PRIMARY TUMOR EXPLANTS BY IN VITRO EXPANDED/ACTIVATED V Delta 1+Gamma Delta T CELLS.
Mavroudis, C.A., Eleftheriou, D., Majumder, B., Sapsford, R., North, J., Lowdell, M., ...Rakhit, R.D. (2012). DEMONSTRATION OF INTRACORONARY MICROPARTICLE EXPRESSION AND THEIR ASSOCIATION WITH ACTIVATED PLATELET MONOCYTE AGGREGATE IN HUMAN ST ELEVATION MYOCARDIAL INFARCTION.
Knight, A., Mackinnon, S., Lowdell, M.W. (2012). Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cells.. CYTOTHERAPY, 14 (9), 1110-1118. doi:10.3109/14653249.2012.700766
Majumder, B., North, J., Mavroudis, C., Rakhit, R., Lowdell, M.W. (2012). Improved accuracy and reproducibility of enumeration of platelet-monocyte complexes through use of doublet-discriminator strategy. Cytometry Part B - Clinical Cytometry,
Majumder, B., North, J., Mavroudis, C., Rakhit, R., Lowdell, M.W. (2012). Improved accuracy and reproducibility of enumeration of platelet-monocyte complexes through use of doublet-discriminator strategy. Cytometry Part B - Clinical Cytometry, 82 B (6), 353-359. doi:10.1002/cyto.b.21040
Sabry, M., Lowdell, M.W. (2012). Natural Killer Cell Responses to Tumor Priming.
Lowdell, M.W. (2012). Natural Killer T cells - balancing the regulation of tumor immunity.. Br J Cancer, 107 (10), 1795-1796. doi:10.1038/bjc.2012.453
Elliott, M.J., De Coppi, P., Speggiorin, S., Roebuck, D., Butler, C.R., Samuel, E., ...Vondrys, D. (2012). Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study. Lancet, 380 994-1000. doi:10.1016/S0140-6736(12)60737-5
Majumder, B., North, J., Mavroudis, C., Rakhit, R., Lowdell, M.W. (2012). Toward new insights on the white blood cell differential by flow cytometry: A proof of concept study on the sepsis model. CYTOMETRY PART B-CLINICAL CYTOMETRY, 82B (6), 353-359. doi:10.1002/cyto.b.21027
Miller, C.E., Pang, H., Brian, D., Pang, K., North, J., Shah, F., ...Hart, S. (2012). Transition to an integrated reporting system for bone marrow biopsies from patients with suspected haematological malignancy - experience in North Central London/West Essex.
Lowdell, M.W., Birchall, M., Thrasher, A.J. (2012). Use of compassionate-case ATMP in preclinical data for clinical trial applications.. LANCET, 379 (9834), 2341. doi:10.1016/S0140-6736(12)61018-6

2011

Peggs, K.S., Thomson, K., Samuel, E., Dyer, G., Armoogum, J., Chakraverty, R., ...Lowdell, M.W. (2011). Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation.. CLINICAL INFECTIOUS DISEASES, 52 (1), 49-57. doi:10.1093/cid/ciq042
Mattes, F.M., Vargas, A., Kopycinski, J., Hainsworth, E.G., Sweny, P., Nebbia, G., ...Phillips, R.E. (2011). Erratum: Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation (American Journal of Transplantation (2008) 8 (990-999) DOI: 10.1111/j.1600-6143.2008.02191.x). American Journal of Transplantation, 11 (5), 1107-. doi:10.1111/j.1600-6143.2011.03549.x
Mattes, F.M., Vargas, A., Kopycinski, J., Hainsworth, E.G., Sweny, P., Nebbia, G., ...Phillips, R.E. (2011). Functional Impairment of Cytomegalovirus Specific CD8 T Cells Predicts High-Level Replication After Renal Transplantation. American Journal of Transplantation (vol 8, pg 990, 2008).
Maramba, A., North, J., Lowdell, M.W., Donaldson, C. (2011). IgM ligation triggers Zeta associated protein of 70 kDa (ZAP-70) tyrosine 292 and 319 phosphorylation in B-Chronic lymphocytic leukaemia (B-CLL).
Sabry, M., Tsirogianni, M., Bakhsh, I.A., North, J., Sivakumaran, J., Giannopoulos, K., ...Lowdell, M.W. (2011). Leukemic priming of resting NK cells is killer Ig-like receptor independent but requires CD15-mediated CD2 ligation and natural cytotoxicity receptors.. JOURNAL OF IMMUNOLOGY, 187 (12), 6227-6234. doi:10.4049/jimmunol.1101640
Mavroudis, C.A., Majumder, B., Lowdell, M., Rakhit, R.D. (2011). PLATELET MONOCYTE AGGREGATES ARE DETERMINANTS OF MICROVASCULAR DYSFUNCTION DURING PERCUTANEOUS CORONARY INTERVENTION FOR STABLE ANGINA AND NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION.
Mavroudis, C., Majumder, B., Lowdell, M., Rakhit, R. (2011). Platelet Monocyte Aggregates Correlate with Indices of Microvascular Dysfunction (Coronary Wedge Pressure and Index of Microvascular Resistance) During PCI for Stable Angina and Non-ST Segment Elevation Acute Coronary Syndrome.
Lowdell, M.W., Samuel, E. (2011). Processing Cells for Transplantation. In Fehily, D., Brubaker, S., Kearney, J., Wolfinbarger, L. (Eds.), Tissue & cell processing – an essential guide. Oxford: Wiley - Blackwell.
Kottaridis, P., Tsirogianni, M., North, J., Marden, C., Mackinnon, S., Lowdell, M.W. (2011). Results of a Phase 1 Clinical Trial of Allogeneic Tumor-Primed Natural Killer Cells in AML.
Katodritou, E., Terpos, E., North, J., Kottaridis, P., Verrou, E., Gastari, V., ...Tsirogianni, M. (2011). Tumor-primed natural killer cells from patients with multiple myeloma lyse autologous, NK-resistant, bone marrow-derived malignant plasma cells.. AMERICAN JOURNAL OF HEMATOLOGY, 86 (12), 967-973. doi:10.1002/ajh.22163

2010

Schure, U., Magnusson, A., Lahiri, N., Andre, R., Rabbanian, S., Lowdell, M.W., ...Tabrizi, S.J. (2010). CELLULAR SIGNALLING OF HUMAN MONOCYTES IN HUNTINGTON'S DISEASE.
Schure, U., Magnusson, A., Lahiri, N., Andre, R., Rabbanian, S., Lowdell, M.W., ...Tabrizi, S.J. (2010). CELLULAR SIGNALLING OF HUMAN MONOCYTES IN HUNTINGTON'S DISEASE. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 81 (1), A6. doi:10.1136/jnnp.2010.222570.18
Knight, A., Mackinnon, S., Lowdell, M.W. (2010). CMV Reactive gamma/delta T Cells Are Equivalent to Their alpha/beta Counterparts In the Lysis of CMV Infected Targets - Potential for Post Transplant Adoptive Immunotherapy.
Samuel, E.R., Newton, K., Mackinnon, S., Lowdell, M.W. (2010). CMV Reactive T Cells Can Be Isolated From G CSF Mobilised Peripheral Blood Apheresates.
Knight, A., Mackinnon, S., Lowdell, M.W. (2010). CMV-Reactive gamma/delta T Cells Are Equivalent to Their alpha/beta Counterparts In the Lysis of CMV-Infected Targets - Potential for Post Transplant Adoptive Immunotherapy.
Samuel, E.R., Newton, K., Mackinnon, S., Lowdell, M.W. (2010). CMV-Reactive T Cells Can Be Isolated From G-CSF Mobilised Peripheral Blood Apheresates.
Freeman, S., Hills, R., Virgo, P., Couzens, S., Lowdell, M.W., McNamara, C.J., ...Bumett, A. (2010). Detection of Immunophenotypic Residual Disease After Induction Therapy Is An Independent Prognostic Factor for Duration of Remission In Older AML Patients Treated Intensively.
Freeman, S., Hills, R., Virgo, P., Couzens, S., Lowdell, M.W., McNamara, C.J., ...Burnett, A. (2010). Detection of Immunophenotypic Residual Disease After Induction Therapy Is An Independent Prognostic Factor for Duration of Remission In Older AML Patients Treated Intensively.
Kottaridis, P.D., North, J., Marden, C., Grace, S., Jide-Banwo, S., Sivakumaran, J., Lowdell, M.W. (2010). Human NK cells primed by a tumour cell line can be safely transplanted to haploidentical patients with AML and lead to demonstrable GvL activity and long-term NK chimerism.
Andre, R., Schure, U., Magnusson, A., Lahiri, N., Smith, D., Lowdell, M.W., ...Tabrizi, S.J. (2010). MYELOID CELL FUNCTION IN MOUSE MODELS OF HUNTINGTON'S DISEASE.
Andre, R., Schure, U., Magnusson, A., Lahiri, N., Smith, D., Lowdell, M.W., ...Tabrizi, S.J. (2010). MYELOID CELL FUNCTION IN MOUSE MODELS OF HUNTINGTON'S DISEASE. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 81 A5-A6. doi:10.1136/jnnp.2010.222570.17
Majumder, B., Lowdell, M., Gallimore, R., Lachman, H., Coghlan, J.G., Shiu, M.F., Rakhit, R.D. (2010). Positive Correlation of Intracoronary C-Reactive Protein With Platelet-Monocyte Complexes and Serum Amyloid A Protein Suggests Local Interrelationship Between Platelet Activation and Inflammation in the Acute Coronary Syndrome Patients.
Steele, A.J., Prentice, A.G., Cwynarski, K., Hoffbrand, A.V., Hart, S.M., Lowdell, M.W., ...Wickremasinghe, R.G. (2010). The JAK3-selective inhibitor PF-956980 reverses the resistance to cytotoxic agents induced by interleukin-4 treatment of chronic lymphocytic leukemia cells: potential for reversal of cytoprotection by the microenvironment.. BLOOD, 116 (22), 4569-4577. doi:10.1182/blood-2009-09-245811
Knight, A., Madrigal, A.J., Grace, S., Sivakumaran, J., Kottaridis, P., Mackinnon, S., ...Lowdell, M.W. (2010). The role of Vδ2-negative γδ T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation.. BLOOD, 116 (12), 2164-2172. doi:10.1182/blood-2010-01-255166
Majumder, B., Lowdell, M., Sapsford, R., Hurst, J., Coghlan, J.G., Shiu, M.F., Rakhit, R. (2010). Tissue factor expression by platelet bound monocytes correlates with intracoronary inflammation in ST elevation myocardial infarction patients.
Knight, A., Arnouk, H., Britt, W., Gillespie, G.Y., Lowdell, M.W., Cloud, G.A., ...Lamb, L.S. (2010). V delta 1+gamma delta T cells are cytotoxic against glioblastoma multiforme.

2009

Steele, A.J., Prentice, A.G., Hoffbrand, A.V., Yogashangary, B.C., Hart, S.M., Lowdell, M.W., ...Chanalaris, A. (2009). 2-Phenylacetylenesulfonamide (PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells. Blood, 114 (6), 1217-1225. doi:10.1182/blood-2008-11-190587
Steele, A.J., Prentice, A.G., Hoffbrand, A.V., Yogashangary, B.C., North, J.M., Nacheva, E.P., ...Wickremasinghe, R.G. (2009). 2-phenylacetylenesulfonamide (PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells. Blood, 114 (6), 1217-1225.
Peggs, K.S., Thomson, K., Samuel, E., Dyer, G., Armoogum, J., Pang, K., ...Lowdell, M.W. (2009). Adoptive Transfer of CMV-Specific Donor T Cells Following Allogeneic Transplantation Leads to Rapid and Safe Systemic Reconstitution.
Knight, A., Mackinnon, S., Lowdell, M.W. (2009). CMV-Reactive Gamma/Delta T Cells Expanded From CMV Seronegative Normal Healthy Individuals Lyse CMV-Infected Targets - Potential Adoptive Immunotherapy for Recipients of Stem Cell Transplants From CMV Seronegative Donors.
Majumder, B., Lowdell, M., Smith, C., Rakhit, R.D. (2009). Differential expression of local versus systemic platelet-monocyte complexes in the circulation of patients with acute coronary syndrome.
Patel, A.R.C., Jamal, S., Kumar, K., Lear, S., Lowdell, M., Tahami, F., ...Lipman, M.C.I. (2009). EVALUATING BRONCHOALVEOLAR LAVAGE CELLULAR PROFILES USING FLOW CYTOMETRY IN PATIENTS WITH PULMONARY AND SYSTEMIC DISEASE.
Orti, G., Fielding, A., Kottaridis, P., Morris, E., Thomson, K., Lowdell, M., ...Chakraverty, R. (2009). Phase I study of high-stringency CD8-depletion of donor leukocyte transfusions following allogeneic haematopoietic stem cell transplantation.. Transplantation, 88 1312-1318.
Lowdell, M., Morris, E. (2009). Recent advances in in clinical cellular immunotherapy. In Murphy, M.F., Pamphilon, D.H. (Eds.), Practical Transfusion Medicine. (pp. 462-468). Wiley-Blackwell.

2008

Steele, A.J., Prentice, A.G., Hoffbrand, A.V., Yogashangary, B.C., Hart, S.M., Lowdell, M.W., ...Chanalaris, A. (2008). 2-Phenylacetylenesulfonamide (PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells.. Blood, 114 (6), 1217-1225.
Bjorkqvist, M., Wild, E.J., Thiele, J., Silvestroni, A., Andre, R., Lahiri, N., ...Soulet, D. (2008). A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease. Journal of Experimental Medicine, 205 (8), 1869-1877. doi:10.1084/jem.20080178
Kottaridis, P., North, J., Bakhsh, I., Samuel, E., Mackinnon, S., Lowdell, M.W. (2008). A Phase I/II Clinical Trial of Tumour-Activated Allogeneic Natural Killer Cells in AML.
Mackinnon, S., Thomson, K., Verfuerth, S., Peggs, K., Lowdell, M. (2008). Adoptive cellular therapy for cytomegalovirus infection following allogeneic stem cell transplantation using virus-specific T cells.. BLOOD CELLS MOLECULES AND DISEASES, 40 (1), 63-67. doi:10.1016/j.bcmd.2007.07.003
Kogelberg, H., Tolner, B., Thomas, G.J., Di Cara, D., Minogue, S., Ramesh, B., ...Meyer, T. (2008). Engineering a single-chain Fv antibody to alpha v beta 6 integrin using the specificity-determining loop of a foot-and-mouth disease virus. J.Mol.Biol., 382 (2), 385-401. doi:10.1016/j.jmb.2008.07.013
Mattes, F.M., Vargas, A., Kopycinski, J., Hainsworth, E.G., Sweny, P., Nebbia, G., ...Phillips, R.E. (2008). Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation. American Journal of Transplantation, 8 (5), 990-999. doi:10.1111/j.1600-6143.2008.02191.x
Lear, S.E., Jamal, S., Lipman, M., Breen, R., Lowdell, M. (2008). Immunophenotyping of Alveolar FluidWe present a locally-developed procedure for routine use in the UK diagnostic laboratory.
Orti, G., Peggs, K., Thomson, K., Morris, E., Lowdell, M., Mackinnon, S., Chakraverty, R. (2008). Phase I Study of Transfer of CD8 Depleted Donor Leukocytes after Allogencic Stem Cell Transplantation..

2007

Lindsey, W.B., Lowdell, M.W., Marti, G.E., Abbasi, F., Zenger, V., King, K.M., Lamb, L.S. (2007). CD69 expression as an index of T-cell function: assay standardization, validation and use in monitoring immune recovery.. CYTOTHERAPY, 9 (2), 123-132. doi:10.1080/14653240601182838
Vasilcan, M., O'Brien, F., Sekhavat, M., Mackinnon, S., Lowdell, M.W. (2007). Clean-room conditions for HPC processing have no impact on incidence of product contamination or on clinical outcome.
Kogelberg, H., Tolner, B., Sharma, S.K., Lowdell, M.W., Qureshi, U., Robson, M., Hillyer, T. (2007). Clearance mechanism of a mannosylated antibody-enzyme fusion protein used in experimental cancer therapy (vol 17, pg 36, 2007). GLYCOBIOLOGY, 17 (10), 1030. doi:10.1093/glycob/cw1053
Lowdell, M.W., Thomson, K., Julie, A., Pang, K., Samuel, E., Desborough, M., Mackinnon, S. (2007). Direct isolation and infusion of donor-derived CMV-specific T cells for treatment or prophylaxis of CMV infection following allogeneic transplantation.
Lowdell, M.W., Thomson, K., Armoogum, J., Pang, K., Samuel, E., Desborough, M., Mackinnon, S. (2007). Direct isolation of donor-derived CMV-specific T-cells and their adoptive transfer for treatment or prophylaxis of CMV infection following allogeneic HSCT.
Laurson, J., Selden, C., Clements, M., Mavri-Damelin, D., Coward, S., Lowdell, M., Hodgson, H.J. (2007). Putative human liver progenitor cells in explanted liver. Cells Tissues.Organs, 186 (3), 180-191.
Laurson, J., Selden, C., Clements, M., Mavri-Damelin, D., Coward, S., Lowdell, M., Hodgson, H.J.F. (2007). Putative human liver progenitor cells in explanted liver. CELLS TISSUES ORGANS, 186 (3), 180-191. doi:10.1159/000106360
Lowdell, M.W., North, J., Bakhsh, I., Marden, C., Anderson, R., Pittman, H., Mackinnon, S. (2007). Tumor-activated human NK cells - Potential for "off-the-shelf" immunotherapy.
North, J., Bakhsh, I., Marden, C., Pittman, H., Addison, E., Navarrete, C., ...Lowdell, M.W. (2007). Tumor-primed human natural killer cells lyse NK-resistant tumor targets: evidence for a two-stage process in resting NK cell activation.. The Journal of Immunology, 178 85-94.

2006

Kogelberg, H., Tolner, B., Sharma, S.K., Lowdell, M.W., Qureshi, U., Robson, M., ...Contreras, R. (2006). Clearnce mechanism of mannosylated antibody- enzyme fusion protein used in experimental cancer therapy. Glycobiology, 17 (1), 36-45. doi:10.1093/glycob/cwl053
Thomson, K., Julie, M., Pang, K., Samuel, E., Desborough, M., Lowdell, M.W., Mackinnon, S. (2006). Direct isolation of donor-derived antigen - Specific T cells and their adoptive transfer for treatment or prophylaxis of CMV infection following allogeneic transplantation..
Batten, P., Sarathchandra, P., Antoniw, J.W., Tay, S.S., Lowdell, M.W., Taylor, P.M., Yacoub, M.H. (2006). Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: relevance to tissue engineering human heart valves.. TISSUE ENGINEERING, 12 (8), 2263-2273. doi:10.1089/ten.2006.12.2263
Steele, A.J., Jones, D.T., Ganeshaguru, K., Duke, V.M., Yoganshangary, B.C., North, J.M., ...Prentice, A.G. (2006). The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro. Leukemia, 20 (6), 1073-1079. doi:10.1038/sj.leu.2404230
Steele, A.J., Jones, D.T., Ganeshaguru, K., Duke, V.M., Yogashangary, B.C., North, J.M., ...Prentice, A.G. (2006). The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro. LEUKEMIA, 20 (6), 1073-1079. doi:10.1038/sj.leu.2404230
Raeiszadeh, M., Kopycinski, J., Paston, S.J., Diss, T., Lowdell, M., Hardy, G.A., ...Emery, V. (2006). The T cell response to persistent herpes virus infections in common variable immunodeficiency. Clinical and Experimental Immunology, 146 (2), 234-242. doi:10.1111/j.1365-2249.2006.03209.x
Lowdell, M.W., Bakhsh, I., North, J., Marden, C., Addison, E., Mackinnon, S. (2006). Tumor-activated human NK cells specificall ylyse autologous and allogeneic NK-resistant tumor targets..

2005

Stigliano, R., Marelli, L., Senzolo, M., Pang, K., Lowdell, M., Davies, N., ...Rolando, N. (2005). Are CD34+ cells increased in perpheral blood of patients with HCC. Preliminary data. Hepatology, 42 (4), 742A-743A.
Marden, C.M., North, J., Anderson, R., Bakhsh, I.A., Addison, E., Pittman, H., ...Lowdell, M.W. (2005). CD69 is required for activated NK cell-mediated killing of resistant targets..
Stigliano, R., Morelli, L., Senzolo, M., Morisco, F., Pang, C., Lowdell, M., ...Rolles, K. (2005). Circulating progenitor cells after vascular injury. Gut, 54 A48-A49.
Samuel, E., Sekhavat, M., O'Brien, F., Pang, K., Ankrah, J., Mackinnon, S., Lowdell, M. (2005). Effect of conditioning regimen on the relationship between CD34 cell dose and time to engraftment after allogeneic stem cell transplant.
Stigliano, R., Marelli, L., Pang, K., Lowdell, M., Rolles, K., Patch, D., ...Rolando, N. (2005). G-CSF mobilization of bone marrow-derived hepatocye and haematopoietic progenitors in acute alcoholic hepatitis - A randomised controlled trial. Preliminary data. Hepatology, 42 (4), 741A.
Addison, E.G., North, J., Bakhsh, I., Marden, C., Haq, S., Al-Sarraj, S., ...Lowdell, M.W. (2005). Ligation of CD8alpha on human natural killer cells prevents activation-induced apoptosis and enhances cytolytic activity.. Immunology, 116 (3), 354-361. doi:10.1111/j.1365-2567.2005.02235.x
O'Brien, F., Sekhavat, M., Lowdell, M. (2005). Long-term storage of cryopreserved autologous bone marrow retains viable haematopoietic progenitor cells.
Kogelberg, H., Tolner, B., Lowdell, M., Qureshi, U., Robson, M., Dearling, J.L., ...Taylor, M.E. (2005). Mechansims of clearance of the antibody-directed enzyme prodrug therapeutic, the mannosylated MFE-CP.
Stigliano, R., Marelli, L., Senzolo, M., Pang, C., Lowdell, M., Patch, D., ...Burroughs, A.K. (2005). Peripheral hepatic and haematopoietic stem cells after partial hepatectomy: Preliminary data. Gut, 54 A48.
Marks, A.J., C.o.o.p.e.r., M.S., A.n.d.e.r.s.o.n., R.J., O.r.c.h.a.r.d., ......N.o.r.t.h. (2005). Selective apoptotic killing of malignant hemopoietic cells by antibody targeted delivery of an amphipathic peptide.. Cancer Research, 65 (6), 2373-2377. doi:10.1158/0008-5472.CAN-04-2594

2004

Davies, J., Koh, M., Lowdell, M.W. (2004). Antiviral immunity and T-regulatory cell function are retained after selective alloreactive T-cell depletion in both the HLA-identical and HLA-mismatched settings. Biology of Blood and Marrow Transplantation, 10 (4), 259-268. doi:10.1016/j.bbmt.2003.12.001
Davies, J., Marden, C., Sviland, L., North, J., Lowdell, M.W. (2004). Ex-vivo alloreactive T cell depletion with anti-CD69 - Effects on anti-viral immune-reactivity and donor NK cell function. Blood Cells, Molecules, and Diseases, 33 (3), 198.
Buyck, H.C., Paston, S.J., Lowdell, M.W., MacKinnon, S., Emery, V.C. (2004). Functional helper T cell response to CMV predicts probability of CMV vireamia following allogeneic stem cell transplantation..
Jones, D., Addison, E., North, J., Lowdell, M., Hoffbrand, A.V., Mehta, A., ...Wickremasinghe, R. (2004). Geldanamycin and herbimycin A induce apoptotic killing of B chronic lymphocytic leukemia cells and augment the cells' sensitivity to cytotoxic drugs. Blood, 103 (5), 1855-1861. doi:10.1182/blood-2003-05-1603
Jones, D.T., Addison, E., North, J.M., Lowdell, M.W., Hoffbrand, A.V., Mehta, A.B., ...Wickremasinghe, R.G. (2004). Geldanamycin and herbimycin A induce apoptotic killing of B chronic lymphocytic leukemia cells and augment the cells' sensitivity to cytotoxic drugs. BLOOD, 103 (5), 1855-1861. doi:10.1182/blood-2003-05-1603
Craig, C.E., Quaglia, A., Selden, C., Lowdell, M., Hodgson, H., Dhillon, A. (2004). The histopathology of regeneration in massive hepatic necrosis. SEMINARS IN LIVER DISEASE, 24 (1), 49-64.
Folarin, N.I., Baker, R.J., Duke, V., Yogashangary, B.C., Vadikolia, C., Wickremasinge, R.G., ...Nathwani, A. (2004). Zap-70 and IgVH mutation status in combination with p53 functional analysis identifies the response of poor prognosis B-CLL patients to conventional cytotoxic agents.

2003

Lowdell, M.W. (2003). "Out damned spot": ex vivo purging revisited. BLOOD, 102 (12), 3860-3861.
Davies, J.K., Marden, C., Sviland, L., Lowdell, M.W. (2003). Alloreactive NK cells do not mediate GvHD in the human skin explant model - Implications for development of an allogeneic NK cell recipient conditioning approach. BLOOD, 102 (11), 3542-.
Davies, J.K., Marden, C., Sviland, L., Lowdell, M.W. (2003). Alloreactive NK cells do not mediate GvHD in the human skin explant model - Implications for development of an allogeneic NK cell recipient conditioning approach..
Davies, J.K., Marden, C.M., Sviland, L., Lowdell, M.W. (2003). Alloreactive NK cells do not mediate GvHD in the human skin explant model - implications for development of an allogenic NK cell recipient conditioning approach.
Ganeshaguru, K., Jones, D.T., Folarin, N.I., Marks, A.J., Addison, E., North, J.M., ...Wickremasinghe, R.G. (2003). Ansamysins synergise with conventional drugs in apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells..
Craig, C.E.H., Quaglia, A., Savage, K., Lowdell, M.W., Selden, C., Sim, R., ...Dhillon, A.P. (2003). Hepatocyte progenitor cells in massive hepatic necrosis.
Craig, C.E.H., Quaglia, A., Savage, K., Lowdell, M.W., Seldon, C., Sim, R., ...Dhillon, A.P. (2003). Hepatocyte progenitor cells in massive hepatic necrosis. Journal of Hepatology, 38 (Supple), 38-.
Orleans-Lindsay, J.K., Deru, A., Craig, J.I.O., Prentice, H.G., Lowdell, M.W. (2003). In vitro co-stimulation with anti-CD28 synergizes with IL-12 in the generation of T cell immune responses to leukaemic cells; a strategy for ex-vivo generation of CTL for immunotherapy. Clinical and Experimental Immunology, 133 (3), 467-475.
Marden, C.M., North, J., Little, A.M., Madrigal, J.A., Lowdell, M.W. (2003). In vitro expansion of non-alloreactive leukaemia-restricted T-cells in an HLA-mismatched setting. BLOOD, 102 (11), 3591-.
Marden, C.M., North, J., Little, A., Madrigal, J.A., Lowdell, M.W. (2003). In vitro expansion of non-alloreactive leukaemia-restricted T-cells in an HLA-mismatched setting.
Marden, C.M., North, J., Little, A.M., Madrigal, J.A., Lowdell, M.W. (2003). In vitro expansion of non-alloreactive leukaemia-restricted T-cells in an HLA-mismatched setting..
Lowdell, M.W. (2003). Natural killer cells in haematopoietic stem cell transplantation. Transfusion Medicine, 13 (6), 399-404.
Davies, J.K., Lowdell, M.W. (2003). New advances in acute graft-versus-host disease prophylaxis. Transfusion Medicine, 13 (6), 387-397.
Davies, J.K., Joh, M.B., Prentice, H.G., Lowdell, M.W. (2003). Potentiating the MLR prior to selective depletion of alloreactive cells: investigating the use of pre-treatment of stimulatory T cells with OKT3.
Smith, L., Lowdell, M.W. (2003). Quality issues in stem cell and immunotherapy laboratories. Transfusion Medicine, 13 (6), 417-423.
Davies, J.K., Koh, M.B.C., Verfeurth, S., MACKINNON, S., Lowdell, M.W. (2003). Selective depletion of CD69+ alloreactive donor T-cells by immunomagnetic sorting retains anti-viral activity, T-cell receptor V beta repertoire and functional T-regulatory cells.
Davies, J.K., Koh, M.B., Verfuerth, S., Mackinnon, S., Lowdell, M.W. (2003). Selective depletion of CD69+ alloreactive donor T-cells by immunomagnetic sorting retains anti-viral activity, T-cell receptor V beta repertoire and functional T-regulatory cells within the donor cell pool..
Pamphilon, D.H., Lowdell, M.W. (2003). Stem cells and immunotherapy. Transfusion Medicine, 13 (6), 323-324.
Folarin, N.I., Baker, R.J., Lowdell, M.W., Wickremasinghe, R.G., Marks, A.J., Hoffbrand, A.V., ...Ganeshaguru, K. (2003). ZAP-70 detecting by flow cytometry in cells from chronic lymphocytic leukaemia patients using a highly fluorescent Alexa Flour dye..

2002

Koh, M.B.C., Prentice, H.G., Corbo, M., Morgan, M., Cotter, F.E., Lowdell, M.W. (2002). Alloantigen-specific T-cell depletion in a major histocompatibility complex fully mismatched murine model provides effective graft-versus-host disease prophylaxis in the presence of lymphoid engraftment. British Journal of Haematology, 118 (1), 108-116. doi:10.1046/j.1365-2141.2002.03682.x
Lowdell, M.W., Craston, R., Samuel, D., Wood, M.E., O'Neill, E., Saha, V., Prentice, H.G. (2002). Evidence that continued remission in patients treated for acute leukaemia is dependent upon autologous natural killer cells. British Journal of Haematology, 117 (4), 821-827.
Duarte, R.F., Chen, F.E., Lowdell, M.W., Potter, M.N., Lamana, M.L., Prentice, H.G., Madrigal, J.A. (2002). Functional impairment of human T-lymphocytes following PHA- induced expansion and retroviral transduction: implications for gene therapy. GENE THER, 9 (20), 1359-1368.
Duarte, R.F., Chen, F.E., Lowdell, M.W., Potter, M.N., Lamana, M.L., Prentice, H.G., Madrigal, J.A. (2002). Functional impairment of human T-lymphocytes following PHA-induced expansion and retroviral transduction: implications for gene therapy.. GENE THERAPY, 9 (20), 1359-1368. doi:10.1038/sj.gt.3301807
Duarte, R.F., Chen, F.E., Lowdell, M., Lamana, M.L., Potter, M., Bueren, J.A., ...Madrigal, J.A. (2002). Mechanisms of functional impairment of T lymphocytes following polyclonal expansion for retrovirally mediated gene transfer. TISSUE ANTIGENS, 59 66.
Tiwari, A., Hamilton, G., Seifalian, A.M., Lowdell, M.W., O'Neill, E. (2002). Regarding "Isolation of endothelial cells and their progenitor cells from human peripheral blood". Journal of Vascular Surgery, 35 (4), 827-.
Koh, M.B.C., Cotter, F.E., Prentice, H.G., Lowdell, M.W. (2002). Removal of allo-specific lymphocytes from MHC-mismatched grafts prevents graft-versus-host disease in vivo and retains anti-viral CTL. LEUKEMIA, 16 (3), 411.
Davies, J.K., Koh, M.B., Prentice, H.G., Lowdell, M.W. (2002). Selective allodepletion by immunomagnetic sorting can reduce alloreactivity in vitro, can be done at a clinical scale and preserves in vitro activity against CMV and EBV.. BONE MARROW TRANSPLANTATION, 29 S45-S46.

2001

Orleans-Lindsay, J.K., Barber, L.D., Prentice, H.G., Lowdell, M.W. (2001). Acute myeloid leukaemia cells secrete a soluble factor that inhibits T and NK cell proliferation but not cytolytic function--implications for the adoptive immunotherapy of leukaemia. Clinical and Experimental Immunology, 126 (3), 403-411.
Lowdell, M.W. (2001). Allogeneic immunotherapy of acute leukaemia. CME Bulletin Haematology, 3 (3), 63-66.
Adeyemo, D., Imtiaz, F., Toffa, S., Lowdell, M., Wickremasinghe, R.G., Winslet, M. (2001). Antioxidants enhance the susceptibility of colon carcinoma cells to 5-fluorouracil by augmenting the induction of the bax protein. Cancer Letters, 164 (1), 77-84.
Borràs, F.E., Matthews, N.C., Lowdell, M.W., Navarrete, C.V. (2001). Both lymphoid and myeloid subsets of dendritic cells are present in cord blood. European Journal of Immunogenetics, 28 (2), 259-.
Jones, D.T., Ganeshaguru, K., Virchis, A.E., Folarin, N.I., Lowdell, M.W., Mehta, A.B., ...Wickremasinghe, R.G. (2001). Caspase 8 activation independent of Fas (CD95/APO-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or gamma radiation. Blood, 98 (9), 2800-2807.
Jones, D.T., Ganeshaguru, K., Virchis, A.E., Folarin, N.I., Lowdell, M.W., Mehta, A.B., ...Wickremasinghe, R.G. (2001). Caspase 8 activation independent of Fas (CD95/APO-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or gamma radiation. BLOOD, 98 (9), 2800-2807. doi:10.1182/blood.V98.9.2800
Reynard, M.P., Turner, D., Lowdell, M., Navarrete, C.V. (2001). Cytokine gene polymorphisms associated with outcome of bone marrow transplantation. European Journal of Immunogenetics, 28 (2), 241-.
Lowdell, M.W. (2001). Data analysis in flow cytometry. In McCarthy, D., Macey, M.G. (Eds.), Cytometric Analysis of Cell Phenotype and Function. Cambridge: Cambridge University Press.
Borras, F.E., Matthews, N.C., Lowdell, M.W., Navarrete, C.V. (2001). Identification of both myeloid CD11c(+) and lymphoid CD11c(-) dendritic cell subsets in cord blood. British Journal of Haematology, 113 (4), 925-931.
Hennessy, B., North, J., Deru, A., Llewellyn-Smith, N., Lowdell, M.W. (2001). Measurement of CD2 expression levels of IFN-α-treated fibrosarcomas using cell tracking velocimetry. Cytometry, 44 (2), 137-147. doi:10.1002/1097-0320(20010601)44:2<137::AID-CYTO1093>3.0.CO;2-D
Lowdell, M.W., Lamb, L., Hoyle, C., Velardi, A., Prentice, H.G. (2001). Non-MHC-restricted cytotoxic cells: Their roles in the control and treatment of leukaemias. British Journal of Haematology, 114 (1), 11-24.
Plunkett, F.J., Soares, M.V.D., Annels, N., Hislop, A., Ivory, K., Lowdell, M., ...Akbar, A.N. (2001). The flow cytometric analysis of telomere length in antigen- specific CD8(+) T cells during acute Epstein-Barr virus infection. BLOOD, 97 (3), 700-707.
Hennessy, B., North, J., Deru, A., Llewellyn-Smith, N., Lowdell, M.W. (2001). Use of Leu3a/3b for the accurate determination of CD4 subsets for measurement of intracellular cytokines. CYTOMETRY, 44 (2), 148-152.

2000

Adeyemo, D., Toffa, S., Lowdell, M., Winslet, M. (2000). 5 ASA upregulates 5FU induced Bax expression in colon cancer cells in vitro. BRITISH JOURNAL OF CANCER, 83 58.
Orleans-Lindsay, J.K., Prentice, H.G., Lowdell, M.W. (2000). Acute myleoid leukemia cells induce T cell but not NK cell unresponsiveness - Implications for the adoptive immunotherapy of leukemia.. BLOOD, 96 (11), 116A.
Koh, M.B.C., Prentice, H.G., Corbo, M., Cotter, F.E., Morgan, M., Ravell, P., Lowdell, M.W. (2000). Alloantigen-specific T cell depletion: From the bench to the bedside via a murine model. Hematology and Cell Therapy, 42 (2-3), 187-190.
Adeyemo, D., Toffa, S., Lowdell, M., Winslet, M. (2000). Antioxidants augment 5FU upregulation of Bax expression in colon cancer cells in vitro. British Journal of Cancer, 83 (Suppl),
Lowdell, M.W. (2000). Autologous leukaemia-reactive cd8+ nk cells are required for long-term survival after treatment for acute leukaemia. Blood, 96 (11 PART I),
Lowdell, M.W., Wood, M.E., Samuel, D., Craston, R., Saha, V., Prentice, H.G. (2000). Autologous leukaemia-reactive CD8+NK cells are required for long-term survival after treatment for acute leukaemia.. BLOOD, 96 (11), 119A.
Adeyemo, D., Imtiaz, F., Toffa, S., Lowdell, M., Winslet, M. (2000). BAX/BCL-2 ratio is elevated by combined 5FU and antioxidant in colon cancer cells in vitro. Gut, 46 (11 Apr),
O'Neil, E., Wickremasinghe, R.G., Jackson, T., Prentice, H.G., Lowdell, M.W. (2000). CD8a on human natural killer cells may act as a costimulatory molecule..
O'Neil, E., Wickremasinghe, R.G., Jackson, T., Grant Prentice, H., Lowdell, M.W. (2000). CDSαon human natural killer cells may act as a costimulatory molecule. Blood, 96 (11 PART II),
Lowdell, M.W., Koh, M.B.C. (2000). Immunotherapy of AML: future directions. Journal of Clinical Pathology, 53 (1), 49-54.
Borthwick, N.J., Lowdell, M., Salmon, M., Akbar, A.N. (2000). Loss of CD28 expression on CD8(+) T cells is induced by IL-2 receptor gamma chain signalling cytokines and type I IFN, and increases susceptibility to activation-induced apoptosis. International Immunology, 12 (7), 1005-1013.

1999

Lowdell, M.W., Wood, M.E., Corbo, M., Hennessy, B., Cotter, F.E., Craston, R., Prentice, H.G. (1999). AML-reactive autologous NK cells predict patient survival and can prevent leukaemia outgrowth in an animal model.. BLOOD, 94 (10), 596A.
Koh, M.B.C., Prentice, H.G., Corbo, M., Cotter, F.E., Morgan, M., Ravell, P., Lowdell, M.W. (1999). Establishment of the NOD/SCID mouse as a model for allogeneic GvHD.. BLOOD, 94 (10), 330B.
Lowdell, M.W., Craston, R., Prentice, H.G. (1999). Generation of autologous immunity to acute myeloid leukaemia and maintenance of complete remission following alpha interferon treatment.. BRITISH JOURNAL OF HAEMATOLOGY, 105 78.
Lowdell, M.W., Craston, R., Prentice, H.G. (1999). Generation of autologous immunity to acute myeloid leukaemia and maintenance of complete remission following interferon-alpha treatment.. CYTOKINES CELLULAR & MOLECULAR THERAPY, 5 (2), 119-121.
Lowdell, M.W., Wood, M.E., Craston, R., Prentice, H.G. (1999). Measurement of autologous immunity to leukaemia can predict maintenance of complete remission at two years.. BRITISH JOURNAL OF HAEMATOLOGY, 105 59.
Koh, M.B.C., Prentice, H.G., Corbo, M., Cotter, F.E., Morgan, M., Ravell, P., Lowdell, M.W. (1999). Removal of allo-specific lymphocytes from MHC-mismatched grafts prevents graft-versus-host disease in a NOD/SCID mouse model.. BLOOD, 94 (10), 330B.
Koh, M.B., Prentice, H.G., Lowdell, M.W. (1999). Selective removal of alloreactive cells from haematopoietic stem cell grafts: graft engineering for GVHD prophylaxis.. BONE MARROW TRANSPLANTATION, 23 (10), 1071-1079. doi:10.1038/sj.bmt.1701749
Fierabracci, A., Hammond, L., Lowdell, M., Chiovato, L., Goode, A.W., Bottazzo, G.F., Mirakian, R. (1999). The effect of staphylococcal enterotoxin B on thyrocyte HLA molecule expression. JOURNAL OF AUTOIMMUNITY, 12 (4), 305-314. doi:10.1006/jaut.1999.0279
Koh, M.B.C., Lowdell, M.W., Prentice, H.G. (1999). The GvH reaction: The 'cytokine storm' and its effect on lymphocyte alloreactive responses.. BRITISH JOURNAL OF HAEMATOLOGY, 105 60.
Theocharous, P., Lowdell, M.W., Jones, A.L., Prentice, H.G. (1999). Ultrasensitive immunocytochemical and fluorescent detection and characterisation of circulating and micrometastatic tumour cells in patients with breast cancer.. BRITISH JOURNAL OF HAEMATOLOGY, 105 60.

1998

Koh, M.B.C., Lowdell, M.W., Prentice, H.G. (1998). The differential effects of cytokines on the expression of major histocompatibility antigens and adhesion molecules on lymphocytes.. BLOOD, 92 (10), 60B.
Lowdell, M.W., Craston, R., Ray, N., Koh, M., Galatowicz, G., Prentice, H.G. (1998). The effect of T cell depletion with Campath-1M on immune reconstitution after chemotherapy and allogeneic bone marrow transplant as treatment for leukaemia.. BONE MARROW TRANSPLANTATION, 21 (7), 679-686. doi:10.1038/sj.bmt.1701153
Cohen, S.B.A., Dominiguez, E., Lowdell, M., Madrigal, J.A. (1998). The immunological properties of cord blood: Overview of current research presented at the 2nd EUROCORD Workshop. BONE MARROW TRANSPLANTATION, 22 S22-S25.
Morgan, C.L., Ruprai, A.K., Solache, A., Lowdell, M., Price, C.P., Cohen, S.B.A., ...Newman, D.J. (1998). The influence of exogenous peptide on β2-microglobulin exchange in the HLA complex: Analysis in real-time. IMMUNOGENETICS, 48 (2), 98-107. doi:10.1007/s002510050409
Craston, R., Lowdell, M.W., Prentice, H.G. (1998). The influence of interleukin-2 (IL-2), IL-7 and IL-15 on the development of natural killer cells.. BLOOD, 92 (10), 57B.

1997

Lowdell, M.W., Theocharous, P. (1997). "Less is More": The Role of Purging in Hematopoietic Stem Cell Transplantation.. Oncologist, 2 (4), 268-274. doi:10.1634/theoncologist.2-4-268
Hammond, L.J., Lowdell, M.W., Cerrano, P.G., Goode, A.W., Bottazzo, G.F., Mirakian, R. (1997). Analysis of apoptosis in relation to tissue destruction associated with Hashimoto's autoimmune thyroiditis.. JOURNAL OF PATHOLOGY, 182 (2), 138-144. doi:10.1002/(SICI)1096-9896(199706)182:2<138::AID-PATH810>3.0.CO;2-F
Bainbridge, D.R., Lowdell, M.W., Hannet, I.M., Strauss, K.W., Karpas, A. (1997). Can repeated plasma donation by asymptomatic HIV-infected individuals delay the onset of AIDS?. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES, 352 (1355), 763-770. doi:10.1098/rstb.1997.0060
Anderson, R., Macdonald, I., Corbett, T., Hacking, G., Lowdell, M.W., Prentice, H.G. (1997). Construction and biological characterization of an interleukin-12 fusion protein (Flexi-12): delivery to acute myeloid leukemic blasts using adeno-associated virus.. HUMAN GENE THERAPY, 8 (9), 1125-1135. doi:10.1089/hum.1997.8.9-1125
Theocharous, P., Lowdell, M.W., Jones, A.L., Prentice, H.G. (1997). Detection and characterisation of tumour cells in the peripheral blood of patients with primary breast cancer.. BLOOD, 90 (10), 950.
Anderson, R.J., Galatowicz, G., Macdonald, I.D., Lowdell, M.W., Corbett, T.J., Prentice, H.G. (1997). Detection of adeno-associated virus type 2 in sorted human bone marrow progenitor cells.. EXPERIMENTAL HEMATOLOGY, 25 (3), 256-262.
Lowdell, M.W., Ray, N., Craston, R., Koh, M., Wood, M.E., Prentice, H.G. (1997). Graft-versus-leukaemia immunity can be detected in patients in remission but is absent prior to and during haematological relapse.. BLOOD, 90 (10), 2388.
Theocharous, P., Lowdell, M.W., Jones, A.L., Prentice, H.G. (1997). Immunocytochemical detection of breast cancer cells: a comparison of three attachment factors.. JOURNAL OF HEMATOTHERAPY, 6 (1), 21-29. doi:10.1089/scd.1.1997.6.21
Dominguez, E., Lowdell, M.W., Perez-Cruz, I., Madrigal, A., Cohen, S.B. (1997). Natural killer cell function is altered by freezing in DMSO.. Biochemical Society Transactions, 25 (2), doi:10.1042/bst025175s
Dominguez, E., Lowdell, M.W., PerezCruz, I., Madrigal, A., Cohen, S.B.A. (1997). Natural killer cell function is altered by freezing in DMSO.. BIOCHEMICAL SOCIETY TRANSACTIONS, 25 (2), S175. doi:10.1042/bst025175s
Koh, M.B.C., Lowdell, M.W., Grant Prentice, H. (1997). Selective depletion of alloreactive lymphoctyes in HLA matched pairs. Experimental Hematology, 25 (8), 741-.
Koh, M.B.C., Lowdell, M.W., Prentice, H.G. (1997). Selective depletion of alloreactive lymphocytes in HLA matched pairs.. EXPERIMENTAL HEMATOLOGY, 25 (8), 43.
Koh, M.B.C., Lowdell, M.W., Prentice, H.G. (1997). Selective depletion of alloreactive lymphocytes in HLA matched pairs.. BLOOD, 90 (10), 1870.
Borthwick, N.J., Akbar, A.N., MacCormac, L.P., Lowdell, M., Craigen, J.L., Hassan, I., ...Yong, K.L. (1997). Selective migration of highly differentiated primed T cells, defined by low expression of CD45RB, across human umbilical vein endothelial cells: effects of viral infection on transmigration. Immunology, 90 (2), 272-280.
Borthwick, N.J., Akbar, A.N., MacCormac, L.P., Lowdell, M., Craigen, J.L., Hassan, I., ...Yong, K.L. (1997). Selective migration of highly differentiated primed T cells, defined by low expression of CD45RB, across human umbilical vein endothelial cells: effects of viral infection on transmigration.. Immunology, 90 (2), 272-280.
Craston, R., Koh, M., Mc Dermott, A., Ray, N., Prentice, H.G., Lowdell, M.W. (1997). Temporal dynamics of CD69 expression on lymphoid cells.. JOURNAL OF IMMUNOLOGICAL METHODS, 209 (1), 37-45. doi:10.1016/S0022-1759(97)00143-9
Lowdell, M.W., Ray, N., Craston, R., Corbett, T., Deane, M., Prentice, H.G. (1997). The in vitro detection of anti-leukaemia-specific cytotoxicity after autologous bone marrow transplantation for acute leukaemia.. BONE MARROW TRANSPLANTATION, 19 (9), 891-897. doi:10.1038/sj.bmt.1700756
Lowdell, M.W., Craston, R., Prentice, H.G. (1997). Understanding the Graft-Versus-Leukaemia Reaction.. Hematology (Amsterdam, Netherlands), 2 (3), 193-201. doi:10.1080/10245332.1997.11746336
Lowdell, M.W., Craston, R., Prentice, H.G. (1997). Understanding the graft-versus-leukaemia reaction: Progress towards the immunotherapy of leukaemia. Hematology, 2 (3), 193-201. doi:10.1080/10245332.1997.11746336

1996

Corbett, T., Lowdell, M., Macdonald, I., Anderson, R., Prentice, H.G. (1996). B7.1 is superior to B7.2 in providing costimulation for the generation of cytotoxic effectors..
Nouri, A.M.E., Lowdell, M., Entazami, Z., Tezabwala, B.U., Goode, A., Oliver, R.T.D. (1996). Comparison of immunological changes between subcutaneous and intravenous route of administration of IL-2 in cancer patients. UROLOGIA INTERNATIONALIS, 56 (1), 1-5. doi:10.1159/000282798
Macdonald, I., Anderson, R., Corbett, T., Galatowicz, G., Lowdell, M., Prentice, H.G. (1996). Development of leukaemia vaccines by gene transfer of costimulatory and cytokine genes to AML cells using adeno-associated virus. BRITISH JOURNAL OF HAEMATOLOGY, 93 478.
Corbett, T., Hart, S., Macdonald, I., Anderson, R., Lowdell, M., Prentice, H.G. (1996). Expression of the costimulatory molecules CD80 and CD86 on myeloid leukaemic blasts.
Lowdell, M.W., Bainbridge, D.R. (1996). External quality assurance for CD34 cell enumeration - Results of a preliminary national trial. BONE MARROW TRANSPLANTATION, 17 (5), 849-853.
Lowdell, M.W., Bainbridge, D.R. (1996). External quality assurance for CD34 cell enumeration--results of a preliminary national trial. Royal Microscopical Society Clinical Flow Cytometry Group QA Schemes.. Bone marrow transplantation, 17 (5), 849-853.
Lowdell, M.W., Han, P., Dominguez, E. (1996). Immunobiology of neonatal NK cells. In Cohen, S., Gluckman, E., Rubenstein, P., Madrigal, A.J. (Eds.), Cord Blood Characteristics – role in stem cell transplantation. London: Martin Dunitz.
Lowdell, M.W., Ray, N., Craston, R., Prentice, H.G. (1996). Interferon-alpha treatment after autologous bone marrow transplantation and the development of in vitro anti-leukaemic immune reactivity. BRITISH JOURNAL OF HAEMATOLOGY, 93 477.
Lowdell, M.W., Ray, N., Craston, R., Prentice, H.G. (1996). Interferon-alpha treatment after autologous bone marrow transplantation and the development of in vitro anti-leukaemic immune reactivity. EXPERIMENTAL HEMATOLOGY, 24 (9), 361.
Anderson, R., Macdonald, I., Corbett, T., Lowdell, M., Prentice, H.G. (1996). Interleukin 12 (IL-12) and CD80 co-expression from an adeno-associated virus vector.
Dominguez, E., Lowdell, M.W., Perez, I., Madrigal, A., Cohen, S.B.A. (1996). Natural killer cell function is altered by freezing in DMSO.. IMMUNOLOGY, 89 E52.
Scott, I., Bunce, M., Lowdell, M., OShea, J., Tiercy, J.M., Prentice, G., ...Madrigal, A. (1996). NK and CTL alloreactivity due to HLA-C mismatches in BMT.
Morgan, C.L., Ruprai, A.K., Solache, A., Lowdell, M., Price, C.P., Parham, P., ...Madrigal, J.A. (1996). Real-time analysis of HLA class I stability identifies a novel role for exogenous peptide..
Koh, M.B.C., Lowdell, M.W., Prentice, H.G. (1996). Selective removal of alloreactive lymphocytes from peripheral blood mononuclear cell preparations.. BLOOD, 88 (10), 1001.
Lowdell, M.W., Ray, N., Craston, R., Prentice, H.G. (1996). The application of flow cytometry for the detection and investigation of leukaemia-specific immunity.. IMMUNOLOGY, 89 SI40.
Theocharous, P., Lowdell, M.W., Jones, A., Prentice, H.G. (1996). The detection and genetic analysis of low frequency epithelial tumour cells in patients with breast cancer. BLOOD, 88 (10), 998.
Prentice, H.G., Deane, M., Anderson, R., Corbett, T., Lowdell, M., Macdonald, I. (1996). The immunotherapy of acute leukaemia; From allogeneic bone marrow transplantation to gene therapy..

1995

CRASTON, R.M.I., PRENTICE, H.G., LOWDELL, M.W. (1995). A FLOW CYTOMETRIC METHOD FOR STUDYING NK CELL CONJUGATE FORMATION POST BMT. EXPERIMENTAL HEMATOLOGY, 23 (8), 854.
Macdonald, I., Anderson, R., Corbett, T., Lowdell, M.W., Prentice, H.G. (1995). Adeno-associated virus mediated gene transfer of B7.1 to CD34+ bone marrow cells and acute myeloid leukaemia blasts.. BLOOD, 86 (10), 3994.
Anderson, R., Macdonald, I., Corbett, T., Lowdell, M.W., Prentice, H.G. (1995). Adeno-associated virus mediated transfer of interleukin-12 to human CD34+ bone marrow cells and leukaemic blasts.. BLOOD, 86 (10), 3964.
Dominquez, E., Madrigal, J.A., Lowdell, M.W. (1995). Comparison of umbilical cord blood and adult peripheral blood lymphocytes with respect to reactivity to staphylococcal enterotoxins. BLOOD, 86 (10), 2844.
Lowdell, M.W., Craston, R., Prentice, H.G. (1995). NK cell-mediated specific anti-leukaemic activity after autologous bone marrow transplantation for acute leukaemia.. BLOOD, 86 (10), 1822.
ANDERSON, R., GALATOWICZ, G., MACDONALD, I., LOWDELL, M., PRENTICE, H.G. (1995). PCR DETECTION OF ADENOASSOCIATED VIRUS TYPE-2 IN SORTED HUMAN BONE-MARROW CELLS. EXPERIMENTAL HEMATOLOGY, 23 (8), 936.
MACDONALD, I.D., ANDERSON, R.J., CORBETT, T.J., LOWDELL, M.W., PRENTICE, H.G. (1995). PROMOTER COMPETITION IN A RETROVIRAL CONSTRUCT CONTAINING A DOMINANT SELECTIVE GENE IS NOT REVERSIBLE FOLLOWING WITHDRAWAL OF SELECTIVE PRESSURE. EXPERIMENTAL HEMATOLOGY, 23 (8), 936.
Prentice, H.G., Sekhar, M., Deane, M., Macdonald, I., Anderson, R., Galatowizc, G., ...Lowdell, M.W. (1995). The immunotherapy of acute myeloblastic leukaemia; From allogeneic BMT to gene transfer.. BLOOD, 86 (10), 2455.
Scott, I., Bunce, M., Lowdell, M., OShea, J., Tiercy, J.M., Gavira, N., ...Madrigal, A. (1995). The role of HLA-C mismatching in T cell and natural killer alloreactivity in unrelated donor bone marrow transplant..
Lowdell, M.W., Shamim, F., Hamon, M., Macdonald, I.D., Prentice, H.G. (1995). VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.. EXPERIMENTAL HEMATOLOGY, 23 (14), 1530-1534.

1994

KWAN, J.T.C., LOWDELL, M.W., NAVARRETE, C., CRASTON, R., GREEN, T., GLOVER, M.T., RAFTERY, M.J. (1994). COMPARATIVE IMMUNOLOGICAL STUDIES OF RENAL-TRANSPLANT PATIENTS WITH AND WITHOUT SQUAMOPROLIFERATIVE LESIONS. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 5 (3), 982.
YONG, K., REITTIE, J.E., LOWDELL, M., PANAYIOTIDIS, P., HOFFBRAND, A.V., JEWELL, A.P. (1994). INCREASED SURVIVAL OF CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS CULTURED ON BONE-MARROW-DERIVED ENDOTHELIUM.

1993

Lowdell, M., Franco Bottazzo, G. (1993). IMMUNOLOGY. Autoimmunity and insulin-dependent diabetes. LANCET, 341 (8857), 1378-1379. doi:10.1016/0140-6736(93)90947-F
Tsai Goodman, B., Chambers, T.L., Ramsay, L.E., Sears, M.R., Lowdell, M., Franco Bottazzo, G., Rothenberg, L.S. (1993). PAEDIATRICS. Bronchodilators for bronchiolitis?. The Lancet, 341 (8857), 1380-. doi:10.1016/0140-6736(93)90949-H

1992

MacLean, I.L., Lowdell, M.W., Blake, D.R., Lunec, J., Archer, J.R. (1992). Absence of a specific effect of free radicals on HLA-B27.. ANNALS OF THE RHEUMATIC DISEASES, 51 (8), 963-964. doi:10.1136/ard.51.8.963
O'Toole, C.M., Lowdell, M.W., Chargelegue, D., Colvin, B.T. (1992). Decline in CTL and antibody responses to HIV-1 p17 and p24 antigens in HIV-1-infected hemophiliacs irrespective of disease progression. A 5-year follow-up study.. AIDS RESEARCH AND HUMAN RETROVIRUSES, 8 (8), 1361-1368. doi:10.1089/aid.1992.8.1361
OTOOLE, C.M., GRAHAM, S., LOWDELL, M.W., CHARGELEGUE, D., MARSDEN, H., COLVIN, B.T. (1992). DECLINE IN CTL AND ANTIBODY-RESPONSES TO HIV-1 P17-ANTIGENS AND P24-ANTIGENS IN HIV-1-INFECTED HEMOPHILIACS IRRESPECTIVE OF DISEASE PROGRESSION - A 5-YEAR FOLLOW-UP-STUDY (AIDS RESEARCH AND HUMAN RETROVIRUSES, VOL 8, PG 1361, 1992). AIDS RESEARCH AND HUMAN RETROVIRUSES, 8 (11), 1949.
al Sakkaf, L., Pozzilli, P., Bingley, P.J., Lowdell, M.W., Thomas, J.M., Bonifacio, E., ...Bottazzo, G.F. (1992). Early T-cell defects in pre-type 1 diabetes.. ACTA DIABETOLOGICA, 28 (3-4), 189-192. doi:10.1007/BF00778996
Karpas, A., Lowdell, M., Jacobson, S.K., Hill, F. (1992). Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 89 (17), 8351-8355. doi:10.1073/pnas.89.17.8351
MacLean, L., Macey, M., Lowdell, M., Badakere, S., Whelan, M., Perrett, D., Archer, J. (1992). Sulphydryl reactivity of the HLA-B27 epitope: Accessibility of the free cysteine studied by flow cytometry. ANNALS OF THE RHEUMATIC DISEASES, 51 (4), 456-460. doi:10.1136/ard.51.4.456

1991

JOHNSTON, D.H., LOWDELL, M.W., MARTIN, J.E. (1991). ADENOCARCINOMA OF THE COLON - CHARACTERIZATION OF INFILTRATING LYMPHOCYTES. JOURNAL OF PATHOLOGY, 163 (2), A176.
De Giorgi, L., Lowdell, M.W., Matossian-Rogers, A. (1991). Cellular mechanisms of graft-versus-host disease in a mouse model.. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 33 (5), 567-574.

1990

Kelsey, S.M., Lowdell, M.W., Newland, A.C. (1990). IgG subclass levels and immune reconstitution after T cell-depleted allogeneic bone marrow transplantation.. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 80 (3), 409-412.
O'Toole, C., Lowdell, M. (1990). Infection of human T cells with mycoplasma, inhibition of CD4 expression and HIV-1 gp120 glycoprotein binding, and infectivity. LANCET, 336 (8722), 1067. doi:10.1016/0140-6736(90)92535-P
DODD, S., LOWDELL, M., WYSE, R. (1990). PROGRESSIVE CARDIAC MYONUCLEI POLYPLOIDIZATION STARTS IN EARLY FETAL LIFE.

1989

Roy, V., Veys, P., Jackson, F., Ryan, J., Lowdell, M., Newland, A.C. (1989). Adult respiratory syndrome following autologous bone marrow transfusion. BONE MARROW TRANSPLANTATION, 4 (6), 711-712.
DODD, S., LOWDELL, M., WYSE, R. (1989). PROGRESSIVE CARDIAC MYONUCLEI POLYPLOIDIZATION STARTS IN EARLY FETAL LIFE.
Lowdell, M.W., Lawry, J. (1989). Quality Control in Clinical Flow Cytometry. In Macey, M. (Ed.), Flow Cytometry - clinical applications. Oxford: Blackwell Scientific.
MARTIN, J.E., JENKINS, B.J., ZUK, R.J., LOWDELL, M.W., DORAN, H., BAITHUN, S.I. (1989). THE HISTOPATHOLOGY, EXPRESSION OF B-HUMAN CHORIONIC-GONADOTROPIN AND FLOW CYTOMETRIC ANALYSIS OF INVASIVE TRANSITIONAL CELL-CARCINOMA OF THE BLADDER.
OTOOLE, C.M., LOWDELL, M.W. (1989). THE SEROLOGICAL DETECTION OF RECOMBINANT VACCINIA VIRUS ENCODED HIV-1 GAG PROTEINS IN THE CYTOPLASM OF HUMAN-B CELLS IN THE ABSENCE OF CELL-SURFACE EXPRESSION. SERODIAGNOSIS AND IMMUNOTHERAPY IN INFECTIOUS DISEASE, 3 (5), 329-336. doi:10.1016/0888-0786(89)90041-3

1988

LOWDELL, M.W., OTOOLE, C.M. (1988). DEFECTS IN CELL-MEDIATED-IMMUNITY IN HIV-1 INFECTION - IMPLICATIONS FOR IMMUNOTHERAPY AND VACCINE DEVELOPMENT. SERODIAGNOSIS AND IMMUNOTHERAPY IN INFECTIOUS DISEASE, 2 (4), 251-261. doi:10.1016/0888-0786(88)90014-5
OTOOLE, C., LOWDELL, M., COLVIN, B. (1988). T-CELL CONTROL OF EPSTEIN-BARR VIRUS B-CELL TRANSFORMATION IN HIV SEROPOSITIVE HEMOPHILIACS.

1987

Lowdell, M.W., Bainbridge, D.R. (1987). An automated technique to measure breakdown products of C3 with C3d specificities by peak-rate nephelometry.. MEDICAL LABORATORY SCIENCES, 44 (4), 331-333.
WALI, F.A., BRADSHAW, E.G., SUER, A.H., LOWDELL, M., TUGWELL, A.C., MAKINDE, V. (1987). ATRACURIUM AND COMPLEMENT ACTIVATION IN MAN. MEDICAL SCIENCE RESEARCH-BIOCHEMISTRY, 15 (9-10), 555-556.

1900

Björkqvist, M., Wild, E.J., Thiele, J., Silvestroni, A., Andre, R., Lahiri, N., ...Soulet, D. (1900). A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington’s disease. Journal of Experimental Medicine, 205 1869-1877.
(1900). A phase I trial of allogeneic tumour-activated natural killer lymphocytes for the treatment of selected patients with acute myeloid leukaemia..
Majumder, B. (1900). An investigation into the role of platelet- monocyte interaction and inflammation in coronary artery disease.. (Doctoral Dissertation). UCL (University College London).
Lowdell, M.W. (1900). Clonal Cells and Cell Lines Derived From CTV-1 Cells and Methods of Making and Using Same. GB2010/051326.
Lowdell, M.W. (1900). Compositions and Methods for Treating Metastatic Cancer. US 61/232684.
Lowdell, M.W. (1900). Compositions and Methods for Treating Metastatic Cancer. US 61/232684.
Lowdell, M.W. (1900). Compositions and Methods of Treating Viral Infections. US 61/311220.
Lowdell, M.W. (1900). Experimental design, data analysis and fluorescence quantitation. In Macey, M. (Ed.), Flow Cytometry – principles and applications. New Jersey, USA: Humana Press.
Bultitude, W. (1900). Generating full-length killer-cell immunoglobulin-like receptor (KIR) gene sequences using third generation long-amplicon sequencing to assess the impact of KIR polymorphism on haematopoietic cell transplantation outcomes. (Doctoral Dissertation). UCL (University College London).
Sabry, M. (1900). Human natural killer cell responses to tumour-priming. (Doctoral Dissertation). UCL.
Lowdell, M.W., Selden, C., Hodgson, H. (1900). Liver cell progenitor and use for treatment of liver diseases. WO 2003/006638.
Lowdell, M.W. (1900). Method for activating Natural Killer cells by tumor cell preparation in vitro. WO 2006/097743.
Lowdell, M.W. (1900). Preserved Compositions of Activated NK Cells and Methods of Using the Same. WO 2011/004201.
Elliott, M.J., Coppi, P., Speggiorin, S., Roebuck, D., Butler, C.R., Samuel, E., ...Vondrys, D. (1900). Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study.
Proctor, T. (1900). Translational process engineering for tissue engineered hollow organ advanced therapy investigational medicinal products. (Doctoral Dissertation). UCL (University College London).